4-chloro-1,3,5-trimethyl-1H-pyrazole
- $252 - $592
- Product name: 4-chloro-1,3,5-trimethyl-1H-pyrazole
- CAS: 56079-15-3
- MF: C6H9ClN2
- MW: 144.6
- EINECS:
- MDL Number:MFCD00464340
- Synonyms:4-chloro-1,3,5-trimethyl-1H-pyrazole;1H-Pyrazole, 4-chloro-1,3,5-trimethyl-
4 prices
Selected condition:
Brand
- Apolloscientific
- Matrix Scientific
- SynQuest Laboratories
- TRC
Package
- 500mg
- 1g
- ManufacturerApolloscientific
- Product numberOR956935
- Product description4-Chloro-1,3,5-trimethyl-1H-pyrazole 95%
- Packaging1g
- Price$370
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number036443
- Product description4-Chloro-1,3,5-trimethyl-1H-pyrazole
- Packaging500mg
- Price$252
- Updated2021-12-16
- Buy
- ManufacturerSynQuest Laboratories
- Product number3H32-5-UM
- Product description4-Chloro-1,3,5-trimethyl-1H-pyrazole 95%
- Packaging1g
- Price$592
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberB424073
- Product description4-chloro-1,3,5-trimethyl-1H-pyrazole
- Packaging500mg
- Price$330
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Apolloscientific | OR956935 | 4-Chloro-1,3,5-trimethyl-1H-pyrazole 95% | 1g | $370 | 2021-12-16 | Buy |
Matrix Scientific | 036443 | 4-Chloro-1,3,5-trimethyl-1H-pyrazole | 500mg | $252 | 2021-12-16 | Buy |
SynQuest Laboratories | 3H32-5-UM | 4-Chloro-1,3,5-trimethyl-1H-pyrazole 95% | 1g | $592 | 2021-12-16 | Buy |
TRC | B424073 | 4-chloro-1,3,5-trimethyl-1H-pyrazole | 500mg | $330 | 2021-12-16 | Buy |
Properties
Boiling point :85 °C(Press: 15 Torr)
Density :1.1207 g/cm3(Temp: 23.7 °C)
pka :1.26±0.10(Predicted)
Density :1.1207 g/cm3(Temp: 23.7 °C)
pka :1.26±0.10(Predicted)
Safety Information
Symbol(GHS): | ||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Warning | |||||||||||||||||||||||||||||||||||
Hazard statements: |
|
|||||||||||||||||||||||||||||||||||
Precautionary statements: |
|